Unless you're New Zealand or Australia it's the only way.
I'll be eligible for a jab in May, I have been working from home for a year now.
Unless you're New Zealand or Australia it's the only way.
Join the club. Here in the UK, my eligibility really comes down to Moderna arriving or Novavax being approved (I'm 42 with no other eligibility). I;m not really expecting to get back to the office on a limited basis till June/July at earliest (not helped by the fact that the office I'm based out of is currently a mass Vax centre)
Office/work reopening will have less to do with vax numbers and more to do with hospitalisation numbers. As long as hospitalisation cases stay low, we will continue to reopen, regardless of the overall vax positionBnM wrote: ↑Thu Apr 01, 2021 12:38 am Don't forget, 12 weeks between jabs. It's going to be Oct at earliest. My Dad's first jab was 6th Feb so will be interesting to see when he's called for his second. My text from my Doc's telling people to stop calling them said 10-11 weeks but that's before India went a bit pear shaped. We both had AZ.
My mum just got notice of her 2nd job yesterday for next week, 3 weeks ahead of what she was told to expectBnM wrote: ↑Thu Apr 01, 2021 12:38 am Don't forget, 12 weeks between jabs. It's going to be Oct at earliest. My Dad's first jab was 6th Feb so will be interesting to see when he's called for his second. My text from my Doc's telling people to stop calling them said 10-11 weeks but that's before India went a bit pear shaped. We both had AZ.
Should be called in sometime this month - reading the smoke signals it looks like they have being keeping stocks back to meet second jab requirements.BnM wrote: ↑Thu Apr 01, 2021 12:38 am Don't forget, 12 weeks between jabs. It's going to be Oct at earliest. My Dad's first jab was 6th Feb so will be interesting to see when he's called for his second. My text from my Doc's telling people to stop calling them said 10-11 weeks but that's before India went a bit pear shaped. We both had AZ.
Sounds fishyMarylandolorian wrote: ↑Thu Apr 01, 2021 10:56 am Got my 2nd Pfizer shot yesterday, so far no side effects, barely a shoulder hake but sometimes it starts a day later.
15 millions J&J doses in the trash.
https://www.forbes.com/sites/rachelsand ... c2bac94e77
I was reading my sport fishing mag.... last weekend , maybe I’ve some side effects after all.tabascoboy wrote: ↑Thu Apr 01, 2021 11:00 amSounds fishyMarylandolorian wrote: ↑Thu Apr 01, 2021 10:56 am Got my 2nd Pfizer shot yesterday, so far no side effects, barely a shoulder hake but sometimes it starts a day later.
15 millions J&J doses in the trash.
https://www.forbes.com/sites/rachelsand ... c2bac94e77
sorry
Mild flu like symptoms all day today but arm seems to be ok.tc27 wrote: ↑Wed Mar 31, 2021 12:18 pm Had the AZ jab today at a village hall in rural Sussex - I am only 38 but my mother lives on our annex and is clinically vulnerable so was asked to get it.
No side affects so far - at risk of groan-gloating I did a big weight session on Monday and my arms are still wrecked so hard to tell.
The doctors surgery here isn't open over easter, which is why they were trying to find arms to stick the remaining vaccine into (hurray for me). Assume that will be repeated over the country. Big slump, but we know that capacity is higher, so it may not effect things that much, since the few extra days supply will get injected quickly enough.
Pfizer has accused the European Union of hampering its Covid vaccine production.
The US drugmaker, which supplies Britain and more than 70 other countries with coronavirus jabs, said new EU rules about the free movement of goods across borders were damaging its ability to export the vaccine.
The rules oblige manufacturers to seek Brussels' approval before exporting every parcel of jabs, which has caused "a significant administrative burden and some uncertainty", said Danny Hendrikse, the pharmaceutical giant's vice-president of global supply.
“Ultimately what we would like our colleagues to do is to focus on making and distributing the vaccine,” he said.
Mr Hendrikse explained the process of gathering all the raw materials needed for jabs was "particularly complex".
"The components don't just come from Europe, but from all over the world," he said, explaining that for one dose, 280 are needed, which come from 86 suppliers in 19 countries.
His comments come amid a fierce dispute Britain and the EU over export controls.
European leaders had threatened to block exports of the vaccine to Britain while demanding that AstraZeneca boost production on the Continent.
The export plan was vetoed, but EU officials said on Wednesday that no jabs would be shipped to the UK if AstraZeneca failed to meet its commitments to the bloc.
There have also been concerns in EU countries over side-effects from the vaccine.
On Wednesday, the EU's medical regulator told Germany and France that they had no reason to stop using AstraZeneca vaccines after its rollout was halted over concerns about a rare blood disease.
Europe's vaccine rollout has been slow, with France administering about 10.7m jabs, far fewer than the UK’s 30.9 million doses. Germany has delivered about 12.9m doses.
It comes as a third wave of the virus is spreading through Europe, with Emmanuel Macron on Wednesday announcing a month-long lockdown in France that includes school closures.
The Pfizer/BioNTech vaccine and Oxford/AstraZeneca vaccine are the two jabs currently in rotation in the UK.
The UK Government began the roll-out of the Pfizer vaccine on Dec 8. Unlike the Pfizer vaccine, the Oxford jab does not require ultra-low temperatures.
The Pfizer vaccine blocks 94 per cent of asymptomatic cases, an Israeli study has shown.
The Israeli ministry of health found that the Pfizer vaccine has an efficacy of 97 per cent against disease and death and 94 per cent against infection without symptoms.
British taxpayers have invested millions of pounds into a Dutch vaccine factory at the centre of a threatened blockade by the European Commission, The Telegraph can disclose.
Thierry Breton, the EU's internal market commissioner, warned that "zero" jabs would be sent to the UK until AstraZeneca had fulfilled its commitments to Brussels, even after Germany suspended routine use of the AstraZeneca vaccine for people aged below 60 because of fears of rare blood clots.
"If [AstraZeneca] does more, we don't have any issue, but as long as it doesn't deliver its commitment to us, the doses stay in Europe," Mr Breton said. "There is no negotiation."
The Halix factory in Leiden was equipped to produce doses of the Oxford/AstraZeneca vaccine after Matt Hancock, the Health Secretary, approved a major investment last April.
The money – reported to be in the region of £21 million – was meant to secure vital shipments to the UK.
The University of Oxford signed a deal with the Dutch firm after identifying the brand new Halix plant as suitable for building up capacity for millions of doses. Scientists from the university then approached Mark Rutte, the Dutch prime minister, with a request for 10 million euros to build barrels capable of holding 1,000 litres of raw vaccine.
"There will probably be a huge demand for vaccines if they successfully pass the tests," the scientists wrote in a letter leaked to the Dutch broadcaster NOS. "Most likely, the quantities of available vaccines will be limited for several months. To avoid major delays, production capacity must be increased now."
But the Dutch failed to sign the deal despite entering initial talks with Halix. The failure to invest meant the EU missed the chance to secure millions of doses for itself, sources suggested.
According to the Dutch media, the promised UK investment was in the region of 25 million Euros, around £21m, although a Department of Health source said the precise reported figure was "incorrect".
On Thursday night, an EU official admitted the bloc had yet to contribute any cash to the Halix factory, saying: "We have checked for any EU funding possibly given to Halix under EU financial instruments but could not identify any support. This does not prejudge any national funding given by member states."
The stand-off over the Halix factory is further complicated by Brussels' demand for vaccines from the two AstraZeneca factories in the UK, which manufacture the vast majority of the AstraZeneca jabs used by Britain.
The commission wants Boris Johnson to release AstraZeneca from its UK contract, which gives Britain first refusal on jabs. It argues that the EU contract with AstraZeneca counts the two British plants as part of the bloc's supply chain.
I think saying that considering the distinction between the supra and national governments interactions + responsibilities, particularly when we know the difference, is pretty meaningless lies at the heart of our attitude towards the EU - a very deliberate and wilful ignorance. There is plenty of distinction drawn within the continent and it is pertinent they at least make those otherwise nothing - nothing - will be learnt from the crisis. If we don't do the same we just spread disinformation and fail to learn the same in our interactions with "our friends and allies".Saint wrote: ↑Sun Mar 14, 2021 3:45 pmOnce the vaccine acquisition process became an EU issue while the delivery was still down to individual countries, and sign-off/approval relies on both, the the conflation of the EU and national politicians becomes inevitable - you might try to separate the two but it;s a distinction that is actually pretty meaningless.TheNatalShark wrote: ↑Sun Mar 14, 2021 2:58 pmBut the problem is you've said it again - where have the EU or EMA said anything about unsafe or unproven? National leaders or the usual bampots in EU parliament yes, but haven't seen anything to date but defence of the vaccine by commission or EMA. Sorry if it seems a pedantic thing and you mean EU = Europe, but it plays into "us vs them"Saint wrote: ↑Sun Mar 14, 2021 2:42 pm
Yeah, I agree it isn't really a European thing - but it can look/feel that way as the EU have been making noises like unsafe, unproven etc before now.
But the decision making on this issue is absolutely nuts, and while it may be being justified in terms of instilling public confidence in the process, the reality is that it's harming confidence each and every time they do this type of thing.
As for the national regulators, have zero idea about them but would hope it is just something like a certainty threshold of MHRA and others of 99.99% vs 99.999% for those ones. I would wonder if they factor in public confidence in these decisions made, and that they feel this transparency is required for their public to 'maintain'/gain confidence, whilst we see it as unnecessary.
Separate, the MHRA response indicates 11 million doses administered in the UK so far, so assuming that is fairly up to date looks like the majority of doses administered so far are Pfizer, which should change I guess. Not sure why we're so secretive/unopen of the data vs other countries.
https://www.gov.uk/government/news/mhra ... 19-vaccine
Anyway, time for match of the weekend
As has been noted elsewhere, the UK is being secretive as they;re wary of other countries looking at our deployment and potentially using that data to block exports etc. While I dislike the concept, I can understand it in light of the EU's behaviour specifically with regards to AZ. The simple, unhappy, truth is that no other country can be trusted not to interfere in supply contracts if they believe that they might gain political capital from it - and on the flip side, the current UK government is doing all it can to gain it's own capital about being ahead of the curve.
Just so we've got this clear then. The UK directly owns most of the production capacity in the UK (via VMIC) and has now made significant investment into one of the two sites in the EU which has allowed it to scale to the required size.BnM wrote: ↑Fri Apr 02, 2021 1:06 am https://www.telegraph.co.uk/news/2021/0 ... ccine-row/
British taxpayers have invested millions of pounds into a Dutch vaccine factory at the centre of a threatened blockade by the European Commission, The Telegraph can disclose.
Thierry Breton, the EU's internal market commissioner, warned that "zero" jabs would be sent to the UK until AstraZeneca had fulfilled its commitments to Brussels, even after Germany suspended routine use of the AstraZeneca vaccine for people aged below 60 because of fears of rare blood clots.
"If [AstraZeneca] does more, we don't have any issue, but as long as it doesn't deliver its commitment to us, the doses stay in Europe," Mr Breton said. "There is no negotiation."
The Halix factory in Leiden was equipped to produce doses of the Oxford/AstraZeneca vaccine after Matt Hancock, the Health Secretary, approved a major investment last April.
The money – reported to be in the region of £21 million – was meant to secure vital shipments to the UK.
The University of Oxford signed a deal with the Dutch firm after identifying the brand new Halix plant as suitable for building up capacity for millions of doses. Scientists from the university then approached Mark Rutte, the Dutch prime minister, with a request for 10 million euros to build barrels capable of holding 1,000 litres of raw vaccine.
"There will probably be a huge demand for vaccines if they successfully pass the tests," the scientists wrote in a letter leaked to the Dutch broadcaster NOS. "Most likely, the quantities of available vaccines will be limited for several months. To avoid major delays, production capacity must be increased now."
But the Dutch failed to sign the deal despite entering initial talks with Halix. The failure to invest meant the EU missed the chance to secure millions of doses for itself, sources suggested.
According to the Dutch media, the promised UK investment was in the region of 25 million Euros, around £21m, although a Department of Health source said the precise reported figure was "incorrect".
On Thursday night, an EU official admitted the bloc had yet to contribute any cash to the Halix factory, saying: "We have checked for any EU funding possibly given to Halix under EU financial instruments but could not identify any support. This does not prejudge any national funding given by member states."The stand-off over the Halix factory is further complicated by Brussels' demand for vaccines from the two AstraZeneca factories in the UK, which manufacture the vast majority of the AstraZeneca jabs used by Britain.
The commission wants Boris Johnson to release AstraZeneca from its UK contract, which gives Britain first refusal on jabs. It argues that the EU contract with AstraZeneca counts the two British plants as part of the bloc's supply chain.
You forgot the bit where that means that therefore the EU should have 1st dibs on any vaccine produced in any of those, even though they've completely destroyed the confidence of their public in them.
I feel it does! Whenever someone raises how well the vaccination program is going in the UK, I feel the need to raise the disaster in all other areas, so don't think I need to avoid pointing out the negatives/positives elsewhere either.Saint wrote: ↑Fri Apr 02, 2021 10:08 amI didn't think that needed re-iterating at this stage
That's the only health issue I have so can't complainMarylandolorian wrote: ↑Fri Apr 02, 2021 3:05 pmBad knees are not pre existing condition to cut the line.
Saint wrote: ↑Fri Apr 02, 2021 4:06 pm 589K doses yesterday, 435K of which were 2nd doses; just shy of 5 million now double dosed.
Over Easter data for cases, deaths and vaccinations will be updated daily but with some variations.....
England: data updated daily
Northern Ireland: no cases and deaths data on 4 April
Scotland: data updated daily
Wales: no data on 2 April and 4 April (note: cases and deaths data released on 5 April and 6 April will both cover 48 hour periods)
The 7 day rolling average is actually ticking up slightly at the moment - only just off the peak (560K vs 602K)Ovals wrote: ↑Fri Apr 02, 2021 4:21 pmSaint wrote: ↑Fri Apr 02, 2021 4:06 pm 589K doses yesterday, 435K of which were 2nd doses; just shy of 5 million now double dosed.
Over Easter data for cases, deaths and vaccinations will be updated daily but with some variations.....
England: data updated daily
Northern Ireland: no cases and deaths data on 4 April
Scotland: data updated daily
Wales: no data on 2 April and 4 April (note: cases and deaths data released on 5 April and 6 April will both cover 48 hour periods)
Vaccine numbers seem to be staying pretty high - good to see the 2nd doses climbing rapidly.